- “Use or employ, or attempt to use or employ any manipulative device, scheme or artifice to defraud”;
- “Make, or attempt to make, any untrue or misleading statement of a material fact or to omit to state a material fact necessary in order to make the statement made not untrue or misleading”;
- “Engage, or attempt to engage, in any act, practice, or course of business, which operates or would operate as a fraud or deceit upon any person”; or,
- “Deliver or cause to be delivered, or attempt to deliver or cause to be delivered, for transmission through … any means of communication whatsoever, a false or misleading or inaccurate report concerning crop or market information or conditions that affect or tend to affect the price of any commodity in interstate commerce, knowing, or acting in reckless disregard of the fact that such report is false, misleading or inaccurate.”
Regulatory Overhaul in US/EMEA Transforms OTC Derivatives Market
July 22nd, 2015
Actimize FMC Product Team, Financial Markets Compliance

Reading over the media coverage of the Fifth Anniversary of Dodd-Frank this week, made me think about how much things have changed in such a short time — not just in terms of the massive regulatory overhaul in our capital markets, but particularly in the OTC derivatives markets and how we all do business today. In recent years, financial markets in the both United States and in EMEA have changed enormously. The markets have become increasingly global, new trading venues, platforms, and products have entered the market, and technological developments, including high frequency trading (HFT), have had such an impact that new rules were written to address their influence. In the US, the Commodity Futures Trading Commission (CFTC) has broad statutory authority to prohibit and prosecute fraud, deception, price manipulation, and false reporting. And as we all know, the Securities Exchange Commission (SEC) broadly prohibits fraud-based manipulative schemes and even the attempt to use such schemes “in connection with any exchange based swap, or contract of sale of any commodity in interstate commerce.” Both organizations have increased in breadth and influence over the past five years. CFTC Rules 180.1 and 180.2 are relatively new statutory anti-manipulation powers. These rules prohibit any person, directly or indirectly, in connection with a swap, sales contract for any commodity, or any futures contract or related option to “intentionally or recklessly”: